Cell Therapy Program Expands
February 15, 2021
With the addition of four scientists, the team is developing new and innovative approaches to CAR-T therapy in children.
Content related to New cGMP Facility to Benefit Patient Care and Research
Children’s Hospital Los Angeles to Initiate Clinical Trial for Kids with Treatment-Resistant Leukemia
April 6, 2016
The Children’s Center for Cancer and Blood Diseases (CCCBD) at Children’s Hospital Los Angeles is one of the first sites in the world to offer a promising new investigational therapy to treat
CHLA Joins CureWorks Collaborative to Accelerate Development of Immunotherapy Treatments for Childhood Cancers
June 18, 2018
Seattle Children’s, with participating members Children’s Hospital Los Angeles, Children’s National Health System and BC Children’s Hospital, has launched CureWorks, an international collaborative of
The Petersen Foundation Endowment Supports Three Signature Programs at CHLA
June 27, 2020
A generous endowment will help fund clinical care and research in the Cancer and Blood Disease Institute, The Vision Center and Inpatient Rehabilitation.
Unique Next Generation Sequencing-Based Panel Designed for Pediatric Cancer Research
February 18, 2016
Children’s Hospital Los Angeles (CHLA) and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay
Diet + Exercise + Chemo = Increased Survival in Youth with Leukemia
April 1, 2021
Children’s Hospital Los Angeles study finds risk of detectable cancer cells decreased by 70% after one month of treatment in patients with ALL.
Clinical Trial Results: Patients with Leukemia Show High Remission Rates after Immunotherapy
October 16, 2014
Researchers at Children's Hospital Los Angeles have published results of this study in Lancet.
Diet + Exercise + Chemo = Increased Survival in Youth with Leukemia
April 1, 2021
Risk of detecting cancer cells decreased by 70% after one month of treatment